Learn more

CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA BIOCUBAFARMA

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    145,514
  • Filing trend
    0.0%
About

CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA BIOCUBAFARMA has a total of 12 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in Cuba. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are PANTARHEI BIOSCIENCE BV, SCHENTAG JEROME J and SHANXI PROVINCIAL PEOPLES HOSPITAL.

Patent filings in countries

World map showing CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA BIOCUBAFARMAs patent filings in countries
# Country Total Patents
#1 Cuba 12

Patent filings per year

Chart showing CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA BIOCUBAFARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 González Blanco Sonia 6
#2 Besada Pérez Vladimir Armando 3
#3 Guillén Nieto Gerardo Enrique 3
#4 Berlanga Acosta Jorge Amador 3
#5 Morán Valdivia Rolando 2
#6 Wong Padilla Idania 2
#7 Somontes Sánchez Danalay 2
#8 Ubieta Gómez Raimundo 2
#9 Rodríguez Álvarez Yunier 2
#10 Vázquez Castillo Mariela 2

Latest patents

Publication Filing date Title
CU20190071A7 BIOPESTICIDE AND BIOFERTILIZING COMPOSITION
CU20180150A7 ELECTROPHORESIS EQUIPMENT FOR THE FRACTIONATION OR PURIFICATION OF BIOMOLECULES
CU20180117A7 SOLID COMPOSITION FOR AGRICULTURAL AND VETERINARY USE, INCLUDING BACTERIAL STRAIN OF BREVIBACTERIUM CELERE
CU20180092A7 PHARMACEUTICAL COMBINATION CONTAINING THE EPIDERMAL GROWTH FACTOR (EGF) AND THE GHRP6 SECRETAGOGUE PEPTIDE FOR THE RESTORATION OF BRAIN DAMAGE
CU20170176A7 PHARMACEUTICAL COMPOSITION THAT INCLUDES APL TYPE PEPTIDE
CU20160194A7 VACCINE COMPOSITION THAT INCLUDES ONE MUTANT OF HUMAN INTERLEUCINE-15
CU20160161A7 VACCINE COMPOSITION INCLUDING A SECRETAGOGUE PEPTIDE OF GROWTH HORMONE AS A VACCINE ADJUVANT